{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,13]],"date-time":"2026-10-13T19:39:23Z","timestamp":1791920363877,"version":"4.3.4"},"reference-count":17,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2023,1,29]]},"DOI":"10.7759\/cureus.34338","type":"journal-article","created":{"date-parts":[[2023,1,29]],"date-time":"2023-01-29T16:49:33Z","timestamp":1675010973000},"source":"Crossref","is-referenced-by-count":3,"title":["Efficacy of Intralesional Measles Mumps Rubella Vaccine in the Treatment of Verruca Vulgaris: An Interventional Study"],"prefix":"10.7759","author":[{"given":"Ashma  S","family":"Surani","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Raghavon","family":"UN","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yogesh","family":"Marfatia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","reference":[{"key":"ref1","article-title":"","author":"Al Aboud AM","year":"2019","unstructured":"Al Aboud AM, Nigam PK. Wart (Plantar, Verruca Vulgaris, Verrucae). StatPearls, Treasure Island, FL; 2019. https:\/\/www.ncbi.nlm.nih.gov\/books\/NBK431047\/."},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1111\/dth.12336","article-title":"BCG vaccine for immunotherapy in warts: is it really safe in a tuberculosis endemic area?","volume":"29","author":"Daulatabad D","year":"2016","unstructured":"Daulatabad D, Pandhi D, Singal A. BCG vaccine for immunotherapy in warts: is it really safe in a tuberculosis endemic area?. Dermatol Ther. 2016, 29:168-72. 10.1111\/dth.12336","journal-title":"Dermatol Ther"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1046\/j.1525-1470.2003.20318.x","article-title":"Immunotherapy for recalcitrant warts in children using intralesional mumps or Candida antigens","volume":"20","author":"Clifton MM","year":"2003","unstructured":"Clifton MM, Johnson SM, Roberson PK, Kincannon J, Horn TD. Immunotherapy for recalcitrant warts in children using intralesional mumps or Candida antigens. Pediatr Dermatol. 2003, 20:268-71. 10.1046\/j.1525-1470.2003.20318.x","journal-title":"Pediatr Dermatol"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.3121\/cmr.4.4.273","article-title":"An armamentarium of wart treatments","volume":"4","author":"Lipke MM","year":"2006","unstructured":"Lipke MM. An armamentarium of wart treatments. Clin Med Res. 2006, 4:273-93. 10.3121\/cmr.4.4.273","journal-title":"Clin Med Res"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1111\/j.1468-3083.2008.02719.x","article-title":"Intralesional immunotherapy with killed Mycobacterium w vaccine for the treatment of ano-genital warts: an open label pilot study","volume":"22","author":"Gupta S","year":"2008","unstructured":"Gupta S, Malhotra AK, Verma KK, Sharma VK. Intralesional immunotherapy with killed Mycobacterium w vaccine for the treatment of ano-genital warts: an open label pilot study. J Eur Acad Dermatol Venereol. 2008, 22:1089-93. 10.1111\/j.1468-3083.2008.02719.x","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1128\/CDLI.8.2.209-220.2001","article-title":"Cell-mediated immune response to human papillomavirus infection","volume":"8","author":"Scott M","year":"2001","unstructured":"Scott M, Nakagawa M, Moscicki AB. Cell-mediated immune response to human papillomavirus infection. Clin Diagn Lab Immunol. 2001, 8:209-20. 10.1128\/CDLI.8.2.209-220.2001","journal-title":"Clin Diagn Lab Immunol"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1111\/j.1468-3083.2010.03611.x","article-title":"Intralesional immunotherapy of common warts: successful treatment with mumps, measles and rubella vaccine","volume":"24","author":"Nofal A","year":"2010","unstructured":"Nofal A, Nofal E. Intralesional immunotherapy of common warts: successful treatment with mumps, measles and rubella vaccine. J Eur Acad Dermatol Venereol. 2010, 24:1166-70. 10.1111\/j.1468-3083.2010.03611.x","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1111\/j.1525-1470.2008.00630.x","article-title":"One-year experience with candida antigen immunotherapy for warts and molluscum","volume":"25","author":"Maronn M","year":"2008","unstructured":"Maronn M, Salm C, Lyon V, Galbraith S. One-year experience with candida antigen immunotherapy for warts and molluscum. Pediatr Dermatol. 2008, 25:189-92. 10.1111\/j.1525-1470.2008.00630.x","journal-title":"Pediatr Dermatol"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1067\/mjd.2000.103631","article-title":"Squaric acid immunotherapy for warts in children","volume":"42","author":"Silverberg NB","year":"2000","unstructured":"Silverberg NB, Lim JK, Paller AS, Mancini AJ. Squaric acid immunotherapy for warts in children. J Am Acad Dermatol. 2000, 42:803-8. 10.1067\/mjd.2000.103631","journal-title":"J Am Acad Dermatol"},{"key":"ref10","doi-asserted-by":"crossref","DOI":"10.1590\/S1413-86702004000100001","article-title":"Immune cellular response to HPV: current concepts","volume":"8","author":"Gon\u00e7alves MA","year":"2004","unstructured":"Gon\u00e7alves MA, Donadi EA. Immune cellular response to HPV: current concepts. Braz J Infect Dis. 2004, 8:1-9.","journal-title":"Braz J Infect Dis"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.4103\/2277-9175.129701","article-title":"Efficacy of intralesional injection of mumps-measles-rubella vaccine in patients with wart","volume":"3","author":"Zamanian A","year":"2014","unstructured":"Zamanian A, Mobasher P, Jazi GA. Efficacy of intralesional injection of mumps-measles-rubella vaccine in patients with wart. Adv Biomed Res. 2014, 3:107. 10.4103\/2277-9175.129701","journal-title":"Adv Biomed Res"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.1111\/ced.12369","article-title":"Two-year experience of using the measles, mumps and rubella vaccine as intralesional immunotherapy for warts","volume":"39","author":"Na CH","year":"2014","unstructured":"Na CH, Choi H, Song SH, Kim MS, Shin BS. Two-year experience of using the measles, mumps and rubella vaccine as intralesional immunotherapy for warts. Clin Exp Dermatol. 2014, 39:583-9. 10.1111\/ced.12369","journal-title":"Clin Exp Dermatol"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.1111\/ijd.12480","article-title":"Treatment of recalcitrant warts with intralesional measles, mumps, and rubella vaccine: a promising approach","volume":"54","author":"Nofal A","year":"2015","unstructured":"Nofal A, Nofal E, Yosef A, Nofal H. Treatment of recalcitrant warts with intralesional measles, mumps, and rubella vaccine: a promising approach. Int J Dermatol. 2015, 54:667-71. 10.1111\/ijd.12480","journal-title":"Int J Dermatol"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.4103\/idoj.IDOJ_142_18","article-title":"The efficacy and safety of intralesional immunotherapy with measles, mumps, rubella virus vaccine for the treatment of common warts in adults","volume":"10","author":"Chauhan PS","year":"2019","unstructured":"Chauhan PS, Mahajan VK, Mehta KS, Rawat R, Sharma V. The efficacy and safety of intralesional immunotherapy with measles, mumps, rubella virus vaccine for the treatment of common warts in adults. Indian Dermatol Online J. 2019, 10:19-26. 10.4103\/idoj.IDOJ_142_18","journal-title":"Indian Dermatol Online J"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.18203\/2320-6012.ijrms20161223","article-title":"A prospective randomized open label comparative study of efficacy and safety of intralesional measles, mumps, rubella vaccine versus 100% trichloroacetic acid application in the treatment of common warts","volume":"5","author":"Saini S","year":"2016","unstructured":"Saini S, Dogra N, Dogra D. A prospective randomized open label comparative study of efficacy and safety of intralesional measles, mumps, rubella vaccine versus 100% trichloroacetic acid application in the treatment of common warts. International Journal of Research in Medical Sciences. 2016, 5:1529-33. 10.18203\/2320-6012.ijrms20161223","journal-title":"International Journal of Research in Medical Sciences"},{"key":"ref16","doi-asserted-by":"publisher","DOI":"10.4103\/idoj.IDOJ_111_18","article-title":"A randomized double blind controlled study comparing the efficacy of intralesional MMR vaccine with normal saline in the treatment of cutaneous warts","volume":"9","author":"Agrawal C","year":"2018","unstructured":"Agrawal C, Vyas K, Mittal A, Khare AK, Gupta LK. A randomized double blind controlled study comparing the efficacy of intralesional MMR vaccine with normal saline in the treatment of cutaneous warts. Indian Dermatol Online J. 2018, 9:389-93. 10.4103\/idoj.IDOJ_111_18","journal-title":"Indian Dermatol Online J"},{"key":"ref17","doi-asserted-by":"publisher","DOI":"10.4103\/ijdd.ijdd_1_17","article-title":"Effect of measles mumps rubella vaccine in treatment of common warts","volume":"3","author":"Dhope A","year":"2017","unstructured":"Dhope A, Madke B, Singh AL. Effect of measles mumps rubella vaccine in treatment of common warts. Indian J Drugs Dermatol. 2017, 3:14-19. 10.4103\/ijdd.ijdd_1_17","journal-title":"Indian J Drugs Dermatol"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/127978-efficacy-of-intralesional-measles-mumps-rubella-vaccine-in-the-treatment-of-verruca-vulgaris-an-interventional-study","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,2,9]],"date-time":"2024-02-09T19:49:49Z","timestamp":1707508189000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/127978-efficacy-of-intralesional-measles-mumps-rubella-vaccine-in-the-treatment-of-verruca-vulgaris-an-interventional-study"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,1,29]]},"references-count":17,"URL":"https:\/\/doi.org\/10.7759\/cureus.34338","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2023,1,29]]}}}